Subconjunctival triamcinolone for the treatment of corneal graft rejection and new vessels

Abstract

1367-0484/$ – see front matter 2008 British Contact Lens Association. Published by doi:10.1016/j.clae.2008.06.009 The authors present a 48-year-old woman who had a rejection episode 6 weeks after routine descemet stripping automated endothelial keratoplasty (DSAEK) for pseudophakic bullous keratopathy. Hourly topical prednisolone acetate (Pred Forte, Allergan) was started. Two weeks later the donor and host corneal oedema had not cleared and new vessels had grown into the interface (Fig. 1). The patient insisted on being compliant with her treatment regimen. A 20 mg subconjunctival injection of Triamcinolone Acetonide (TA) (Kenalog, Bristol-Myers Squibb) was given and the Pred Forte